13F Holdings
中文EN

LDDD Longduoduo Co Ltd

Services-Health Services · OTC · SEC CIK 1892316 · Fiscal year ends 06/30

Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY-71.6%
TTM net income YoY-316.7%
TTM EPS YoY-321.4%
Revenue 3-yr CAGR-38.1%
Net income 3-yr CAGR—

Margins

Gross margin99.1%
Operating margin-88.5%
Net margin-78.3%
FCF margin—
EBITDA margin-79.1%

Returns

ROE-132.6%
ROA-53.9%
ROIC (approx.)—
Asset turnover0.69x

Leverage & solvency

Liabilities / assets80.2%
Debt / equity0.00x
Current ratio1.07x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.44x
Accruals ratio-30.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-06-30FY20252025-06-30FY20242024-06-30FY20232023-06-30FY20222022-06-30
Income statement
Revenue$1.82M$4.26M$7.39M$3.82M$3.24M
Cost of revenue$16,958$91,099$173,349$591,885$1.01M
Gross profit$1.81M$4.17M$7.22M$3.23M$2.23M
SG&A expense$2.44M$3.62M$5.19M$3.20M$9.79M
Operating income-$633,181$552,679$2.03M$29,238-$7.56M
Pretax income-$575,816$714,528$1.89M$31,331-$7.56M
Income tax$66,451$222,268$523,207$10,246$1,576
Net income-$578,631$460,435$1.26M-$39,089-$7.56M
EBITDA-$522,517$689,969$2.13M$96,976-$7.49M
EPS (basic)-0.020.010.04-0.00-0.29
EPS (diluted)-0.020.010.04-0.00-0.29
Weighted avg. shares (diluted)30.02M30.01M30.01M30.00M25.62M
Balance sheet
Cash & equivalents$1.59M$1.64M$1.40M$1.14M$356,672
Inventory———$820$3,032
Current assets$1.78M$1.81M$1.66M$1.31M$424,328
PP&E, net$213,025$280,003$353,486$152,719$109,233
Intangibles———$3,828—
Total assets$2.06M$2.13M$2.06M$1.48M$610,667
Current liabilities$1.28M$830,464$1.26M$2.05M$1.63M
Total liabilities$1.31M$830,464$1.28M$2.05M$1.63M
Shareholders' equity$703,691$1.18M$702,515-$541,957-$928,786
Shares outstanding30.02M30.02M30.01M30.00M30.00M
Cash flow statement
Operating cash flow-$163,109$277,365$582,282$965,337$28,572
Capital expenditure$30,638$59,375$305,495$120,127$111,882
Free cash flow-$193,747$217,990$276,787$845,210-$83,310
Investing cash flow-$30,638-$59,375-$305,495-$125,880-$111,882
Financing cash flow———-$143,333$179,697
Depreciation & amortization$110,664$137,290$102,032$67,738$65,700
Stock-based compensation———$384,500$6.74M

Free plan shows the latest 5 periods; Pro shows all 6 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.